Artiva Biotherapeutics, Inc.(ARTV:US)

Market Cap$285.98M

Key Metrics

Price$5.85

Revenue (TTM)$0

Holders Revenue (TTM)-

Gross Profit (TTM)-

Earnings (TTM)-$90.82M

EBITDA (TTM)-$93.46M

Op. Margin (TTM)-

Dividend Yield-

Holders Yield-

Cash on hand$301.45M

Total Assets$368.63M

Net Assets$347.5M

Total Debt$9.85M

Artiva Biotherapeutics, Inc.(ARTV:US)

Market Cap$285.98M

Price history

Key Metrics

Price$5.85

Revenue (TTM)$0

Holders Revenue (TTM)-

Gross Profit (TTM)-

Earnings (TTM)-$90.82M

EBITDA (TTM)-$93.46M

Op. Margin (TTM)-

Dividend Yield-

Holders Yield-

Cash on hand$301.45M

Total Assets$368.63M

Net Assets$347.5M

Total Debt$9.85M

Financials

NameJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Mar 31, 2022Dec 31, 2021Mar 31, 2021Dec 31, 2020
Revenue
$0$0$0$0$0$0$0$0$0$251K$2.35M$26.66M$0$989K$1.35M$1.42M$111K$0
Cost of Revenue
------------------
Gross Profit
------------------
$26.89M$24.43M$21.93M$22.9M$22.81M$22.17M$18.27M$18.34M$16.19M$14.74M$14.32M$15.85M$15.32M$18.68M$13.47M$12.81M$24.28M$6.07M
Research and Development$21.93M$19.31M$16.99M$17.63M$17.86M$17.05M$13.32M$13.52M$12.33M$11.16M$11.15M$13.07M$11.26M$14.77M$9.71M$8.49M$21.62M$4.37M
Selling, General, and Administrative$4.97M$5.12M$4.94M$5.26M$4.95M$5.12M$4.95M$4.81M$3.86M$3.59M$3.17M$2.78M$4.06M$3.91M$3.77M$4.32M$2.66M$1.7M
Other Operating Expenses------------------
Operating Income
-$26.89M-$24.43M-$21.93M-$22.9M-$22.81M-$22.17M-$18.27M-$18.34M-$16.19M-$14.49M-$11.97M$10.81M-$15.32M-$17.69M-$12.12M-$11.39M-$24.17M-$6.07M
$1.89M$914K$1.16M$1.37M$1.56M$1.86M-$1.65M$863K$1.65M$529K$1.07M$468K-$540K$971K-$0-$18.55M$136K
Non-Operating Interest Income$1.89M$912K$1.16M$1.37M$1.56M$1.86M-$8.52M$1.85M-$676K$650K$583K$418K-$509K$1.02M-$0-$0
Non-Operating Interest Expense---------------$0-$0
Other Income/Expense-$1K$2K-$2K-$3K-$5K-$4K$6.88M-$983K$2.33M-$121K$485K$50K-$31K-$53K-$0-$18.55M$136K
Income Before Tax
-$25.01M-$23.52M-$20.77M-$21.53M-$21.25M-$20.31M-$19.91M-$17.47M-$14.54M-$13.96M-$10.9M$11.28M-$15.86M-$16.72M-$12.12M-$11.39M-$42.72M-$5.93M
Income Tax
------------------
Net Income
-$25.01M-$23.52M-$20.77M-$21.53M-$21.25M-$20.31M-$19.91M-$17.47M-$14.54M-$13.96M-$10.97M$11.28M-$15.86M-$16.72M-$12.12M-$11.39M-$42.72M-$5.93M
Minority Interests
------------------
Preferred Stock Dividends
------------------
Net Income to Common
-$25.01M-$23.52M-$20.77M-$21.53M-$21.25M-$20.31M-$19.91M-$17.47M-$14.54M-$13.96M-$10.97M$11.28M-$15.86M-$16.72M-$12.12M-$11.39M-$42.72M-$5.93M
Shares Outstanding (Basic)
39.41M24.68M-24.48M24.38M24.34M-18.9M23.28M9.36M-9.36M9.36M9.36M9.36M-9.36M-
Shares Outstanding (Diluted)
39.41M24.68M-24.48M24.38M24.34M-18.9M23.28M9.36M-9.36M9.36M9.36M9.36M-9.36M-
EPS (Basic)
-$0.63-$0.95--$0.88-$0.87-$0.83--$0.92-$0.62-$1.49-$1.20-$1.69-$1.79-$1.30--$4.56-
EPS (Diluted)
-$0.63-$0.95--$0.88-$0.87-$0.83--$0.92-$0.62-$1.49-$1.20-$1.69-$1.79-$1.30--$4.56-
EBIT
-$26.89M-$24.43M-$21.93M-$22.9M-$22.81M-$22.17M-$18.27M-$18.34M-$16.19M-$14.49M-$11.97M$10.81M-$15.32M-$17.69M-$12.12M-$11.39M-$24.17M-$5.93M
EBITDA
-$26.2M-$23.76M-$21.27M-$22.24M-$22.17M-$21.54M-$17.65M-$16.73M-$17.94M-$13.64M-$11.38M$11.37M-$14.78M-$17.11M-$11.96M-$11.25M-$24.14M-$5.91M